Stonepine Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-370,000
| Closed | -$3.67M | – | 26 |
|
|
2023
Q1 | $3.67M | Sell |
370,000
-3,356,584
| -90% | -$33.2M | 1.23% | 16 |
|
|
2022
Q4 | $37.2M | Buy |
3,726,584
+893,953
| +32% | +$6.67M | 15.63% | 2 |
|
|
2022
Q3 | $15.6M | Buy |
2,832,631
+670,632
| +31% | +$3.72M | 7.02% | 5 |
|
|
2022
Q2 | $7.89M | Buy |
2,161,999
+468,165
| +28% | +$2.21M | 3.67% | 12 |
|
|
2022
Q1 | $10.2M | Buy |
1,693,834
+542,671
| +47% | +$3.31M | 4.25% | 9 |
|
|
2021
Q4 | $9.7M | Buy |
1,151,163
+239,038
| +26% | +$2.09M | 4.45% | 9 |
|
|
2021
Q3 | $8.26M | Buy |
912,125
+149,942
| +20% | +$1.29M | 3.76% | 8 |
|
|
2021
Q2 | $6.17M | Sell |
762,183
-686,685
| -47% | -$4.71M | 3.23% | 10 |
|
|
2021
Q1 | $7.98M | Sell |
1,448,868
-877,297
| -38% | -$4.34M | 4.31% | 10 |
|
|
2020
Q4 | $7.91M | Buy |
2,326,165
+900,730
| +63% | +$2.37M | 6.05% | 5 |
|
|
2020
Q3 | $2.41M | Sell |
1,425,435
-22,330
| -2% | -$33.7K | 2.51% | 11 |
|
|
2020
Q2 | $2.37M | Sell |
1,447,765
-236,096
| -14% | -$469K | 4.58% | 8 |
|
|
2020
Q1 | $3.23M | Buy |
1,683,861
+32,528
| +2% | +$85.4K | 3.42% | 15 |
|
|
2019
Q4 | $4.71M | Buy |
1,651,333
+188,145
| +13% | +$545K | 3.28% | 11 |
|
|
2019
Q3 | $4.81M | Sell |
1,463,188
-1,117,330
| -43% | -$3.54M | 4.67% | 7 |
|
|
2019
Q2 | $8.39M | Hold |
2,580,518
| – | – | 5.77% | 6 |
|
|
2019
Q1 | $9.65M | Buy |
2,580,518
+395,092
| +18% | +$1.38M | 5.55% | 5 |
|
|
2018
Q4 | $7.54M | Sell |
2,185,426
-392,570
| -15% | -$1.94M | 6.62% | 5 |
|
|
2018
Q3 | $18.5M | Hold |
2,577,996
| – | – | 10.81% | 2 |
|
|
2018
Q2 | $18M | Hold |
2,577,996
| – | – | 10.93% | 3 |
|
|
2018
Q1 | $16.2M | Buy |
2,577,996
+17,682
| +0.7% | +$111K | 8.65% | 5 |
|
|
2017
Q4 | $14.3M | Buy |
2,560,314
+195,607
| +8% | +$891K | 8.59% | 3 |
|
|
2017
Q3 | $11.1M | Buy |
+2,364,707
| New | +$12.5M | 6.52% | 7 |
|
Stonepine Capital Management's APEN Position: Q2 2023 in Review
Stonepine Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 370,000 shares — an estimated $3.67M sold.
Stonepine Capital Management first reported a position in APEN in Q3 2017 and held it in 23 quarters. The position peaked at $37.2M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Stonepine Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Stonepine Capital Management sold 370,000 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $3.67M.
- Stonepine Capital Management first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 23 quarters.
- Stonepine Capital Management's Apollo Endosurgery, Inc. position peaked at $37.2M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Stonepine Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.